Read More

Lixte Biotechnology Holdings Reports That Its Lead Clinical Compound, LB-100, Can Kill Cancer Cells Through Hyper-Stimulation Of Cell Proliferation Signals In Pre-Clinical Models; Shares Halted On Circuit Breaker To The Upside

--THE STUDY ESTABLISHES A NOVEL CONCEPT OF "TUMOR SUPPRESSIVE DRUG RESISTANCE"   --THE COMBINATION OF LB-100 WITH INHIBITORS OF CELLULAR STRESS RESPONSE MODULATORS WAS HIGHLY EFFECTIVE IN

LIXT

Read More

Select Medical And OhioHealth Expand Joint Venture Partnership; Definitive Agreement With Reunion Hospital Holdings To Acquire The Operating Assets Of Reunion Rehabilitation Hospital Located At 3805 Emerald Parkway In Dublin, OH

Add New Inpatient Rehabilitation Hospital and Neuro Transitional Center in Central Ohio MECHANICSBURG, Pa. and COLUMBUS, Ohio, Feb. 7, 2023 /PRNewswire/ -- Select Medical and OhioHealth

SEM